INSIGHTS ON DRUG DEVELOPMENT

  • VEGF Signaling Pathway
    3/24/2025

    In Alzheimer's disease, reduced VEGF levels are linked to neurodegeneration, which can offer therapeutic potential. Discover how experimental treatments show promise in reducing memory impairment and beta-amyloid deposition.

  • A Holistic Approach To Understanding High And Low HEK293 Producer
    4/4/2025

    Despite advancements in AAV-based gene therapy, key aspects of AAV biology and production remain unclear. Find out how researchers are exploring HEK293 subclones to identify traits that enhance viral vector yields.

  • Together, Let's Sail Toward Success
    7/23/2025

    Explore the promise and complexity of gene therapy and see how Cytiva empowers scientists to overcome challenges and accelerate life-changing treatments from lab to patient.

  • Accelerating mRNA Therapy Production With Digital Innovation
    10/21/2025

    Scaling mRNA therapies requires more than innovation—it demands precision. Discover how digital tools like automation and analytics are helping life science companies streamline production.

  • Automation Of 3D Intestinal Organoids Culture
    3/17/2025

    Gain insight into how 3D organoids promise better disease modeling and drug screening and how challenges like assay complexity, reproducibility, and scalability hinder their widespread adoption in drug discovery.

DRUG DEVELOPMENT SOLUTIONS

  • Routine cell culture? Check!

    For researchers who need consistent experimental outcomes, Mateo TL enables all lab members to check and document cell growth status conveniently and comfortably.

    Measure confluency consistently, thereby increasing the confidence in the success of their downstream experiments.

  • Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.

  • MabSelect™ VL resin — protein L resin for affinity capture of antibody Fabs, bispecifics, and other variants containing a kappa light chain.

  • When it comes to solid dosage formulations, the most common challenge formulators face is poor solubility. In numbers: 70% of drugs in development are poorly soluble.

  • Used Carl Zeiss Microscope, with AxioCam MRc5 and H.I.P controls, CE design, serial# 39180008000.